Subscribe Now
Rankings
Magazine
Newsletters
Podcasts
Video On Demand
Fortune Live Media
Fortune Connect
Fortune Education
Fortune Well
Fortune Crypto
Fortune Recommends
rankings
See All Rankings
Fortune 500
Global 500
40 Under 40
GREAT PLACE TO WORK LISTS
Best MBA Programs
Magazine
Newsletters
Podcasts
more
Video On Demand
Fortune Live Media
Fortune Connect
Fortune Education
Fortune Well
Fortune Crypto
Fortune Recommends
SEARCH
SIGN IN
Subscribe Now
AstraZeneca
11 pages
Health
Nasal version of the Oxford/AstraZeneca COVID vaccine fails in U.K. trial
BY
Sophie Mellor
October 11, 2022
Health
Top AstraZeneca heart drug Farxiga sees potential to reach more patients
BY
Bloomberg
August 27, 2022
Health
The most innovative and inventive drug companies of 2022 set the foundation for success before the pandemic
BY
Sy Mukherjee
and
IDEA Pharma
April 20, 2022
Health
New drug that prevents you from catching COVID-19 gets green light in Europe — but it’s been in the U.S. for months and hardly anyone knows about it
BY
Sophie Mellor
March 29, 2022
Finance
Omicron is upping booster jab demand. So why are COVID vaccine makers’ shares tanking?
BY
Jeremy Kahn
December 29, 2021
Health
Moderna hit by shareholders who want to know why its COVID-19 vaccine is so expensive and unavailable in poorer countries
BY
David Meyer
December 27, 2021
Health
AstraZeneca finds its COVID booster delivers adequate protection against Omicron
BY
Suzi Ring
and
Bloomberg
December 23, 2021
Health
AstraZeneca COVID-19 vaccine’s protection against severe illness fades quickly, study finds
BY
Jeremy Kahn
December 21, 2021
Health
EU bulks up its arsenal against Omicron with approval of Novavax vaccine. Investors dump shares
BY
Christiaan Hetzner
December 20, 2021
Health
J&J, Sputnik, and Sinopharm vaccines found to be largely ineffective in fighting Omicron: study
BY
Bloomberg
December 17, 2021
International
Omicron is making scientists redefine what it means to be ‘fully vaccinated’ against COVID
BY
Sophie Mellor
December 13, 2021
Health
Global drugmakers could roll out Omicron-adapted COVID vaccines in 100 days
BY
Yvonne Lau
November 29, 2021
Health
Pfizer’s COVID-19 vaccine generated the strongest immune response in study of 4 jabs
BY
Jason Gale
and
Bloomberg
November 15, 2021
Health
AstraZeneca shifts away from nonprofit model for its COVID-19 vaccine, except when selling to poor countries
BY
David Meyer
November 12, 2021
International
What happens when COVID jabs begin to wane? The U.K. offers up a painful lesson
BY
Sophie Mellor
October 22, 2021
Most Popular
Retail
Cannabis chain once worth $1.7 billion and called the ‘Apple store of weed’ is now nearly failing as the once-hot pot...
February 7, 2023
BY
Verne Kopytoff
Success
‘Resenteeism’ is the latest trend plaguing workers, and it’s even more dangerous than quiet quitting
February 6, 2023
BY
Jane Thier
Finance
Goldman Sachs makes a bold housing market call
February 6, 2023
BY
Lance Lambert
1 - 15 of 164 results
1
2
3
...
11
Next Page